ETF Managers Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

ETF Managers Group’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-28,384	Closed	-$563K	–	773
2021 Q3	$563K	Buy	28,384 +5,702	+25%	+$157K	0.01%	505
2021 Q2	$816K	Sell	22,682 -697	-3%	-$21.4K	0.01%	290
2021 Q1	$564K	Sell	23,379 -13,122	-36%	-$335K	0.01%	396
2020 Q4	$815K	Sell	36,501 -5,212	-12%	-$115K	0.02%	262
2020 Q3	$767K	Buy	41,713 +20,338	+95%	+$421K	0.02%	241
2020 Q2	$528K	Buy	+21,375	New	+$460K	0.02%	259

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return

ETF Managers Group's DRNA Position: Q4 2021 in Review

ETF Managers Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 28,384 shares — an estimated $563K sold.

ETF Managers Group first reported a position in DRNA in Q2 2020 and held it in 6 quarters. The position peaked at $816K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

ETF Managers Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
ETF Managers Group sold 28,384 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $563K.
ETF Managers Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2020 and held it in 6 quarters.
ETF Managers Group's Dicerna Pharmaceuticals, Inc. position peaked at $816K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on ETF Managers Group's 13F filing for Q4 2021, filed 14 Feb 2022.